[1]钱菲菲,周 易.尿路感染诊断治疗中临床微生物检验的病原菌结果分析[J].医学信息,2022,35(23):159-162.[doi:10.3969/j.issn.1006-1959.2022.23.035]
　QIAN Fei-fei,ZHOU Yi.Analysis of Pathogenic Bacteria Results of Clinical Microbiological Examination in the Diagnosis and Treatment of Urinary Tract Infection[J].Journal of Medical Information,2022,35(23):159-162.[doi:10.3969/j.issn.1006-1959.2022.23.035]
点击复制

尿路感染诊断治疗中临床微生物检验的病原菌结果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年23期
页码:
159-162
栏目:
诊疗技术
出版日期:
2022-12-01

文章信息/Info

Title:
Analysis of Pathogenic Bacteria Results of Clinical Microbiological Examination in the Diagnosis and Treatment of Urinary Tract Infection
文章编号:
1006-1959（2022）23-0159-04
作者:
钱菲菲; 周 易
（宜兴市中医医院检验科，江苏 宜兴 214200）
Author(s):
QIAN Fei-fei; ZHOU Yi
(Department of Laboratory,Yixing Traditional Chinese Medicine Hospital,Yixing 214200,Jiangsu,China)
关键词:
生物检验; 尿路感染; 病原菌; 革兰氏阴性菌; 革兰氏阳性菌; 大肠埃希菌
Keywords:
Microbiological test; Urinary tract infection; Pathogenic bacteria; Gram-negative bacteria; Gram-positive bacteria; Escherichia coli
分类号:
R378
DOI:
10.3969/j.issn.1006-1959.2022.23.035
文献标志码:
A
摘要:
目的 分析尿路感染诊断治疗中临床微生物检验的病原菌情况。方法 选取2020年1月-2021年12月宜兴市中医医院收治的363例尿路感染患者，均行微生物检验，分析尿路感染致病菌的构成及分布情况以及不同性别、易感因素致病菌分布情况，并对尿路感染致病菌的耐药性进行分析。结果 363例尿路感染患者的检验结果中革兰氏阴性菌301例，占比82.92%；革兰氏阳性菌58例，占比15.98%；真菌4例，占比1.10%。男性大肠埃希菌检出率低于女性，肺炎克雷伯菌、铜绿假单胞菌、金黄色葡萄球菌及粪肠球菌检出率高于女性（P＜0.05）。部分致病菌在不同易感因素中检出率比较，差异有统计学意义（P＜0.05）。药敏试验显示，革兰氏阴性菌与革兰氏阳性菌氨苄西林、红霉素、复方新诺明、左氧氟沙星、环丙杀星、青霉素、氯洁霉素耐药性比较，差异有统计学意义（P＜0.05）；二者庆大霉素耐药性比较，差异无统计学意义（P＞0.05）。结论 尿路感染的致病菌种类较多，其中以革兰氏阴性菌最为常见，各项病原菌在不同性别及易感因素病例中的检出情况不同，且耐药性各异。
Abstract:
Objective To analyze the pathogenic bacteria of clinical microbiological examination in the diagnosis and treatment of urinary tract infection.Methods A total of 363 patients with urinary tract infection admitted to Yixing Traditional Chinese Medicine Hospital from January 2020 to December 2021 were selected for microbiological examination. The composition and distribution of pathogenic bacteria in urinary tract infection and the distribution of pathogenic bacteria in different genders and susceptible factors were analyzed, and the drug resistance of pathogenic bacteria in urinary tract infection was analyzed.Results 363 cases of patients with urinary tract infection test results in 301 cases of gram-negative bacteria, accounting for 82.92% ; gram-positive bacteria in 58 cases, accounting for 15.98%; fungi 4 cases, accounting for 1.10%. The detection rate of Escherichia coli in male was lower than that in female, and the detection rates of Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecalis were higher than those in female (P<0.05). The detection rate of some pathogenic bacteria in different predisposing factors was statistically significant (P<0.05). Drug sensitivity test showed that there were significant differences in drug resistance between Gram-negative bacteria and Gram-positive bacteria ampicillin, erythromycin, cotrimoxazole, levofloxacin, ciprofloxacin, penicillin and chloramphenicol (P<0.05). There was no significant difference in gentamicin resistance between the two groups (P>0.05).Conclusion There are many types of pathogenic bacteria in urinary tract infections, among which gram-negative bacteria are the most common. The detection of various pathogens in cases of different genders and susceptibility factors is different, and the drug resistance is different.

参考文献/References:

[1]蒋文艳,唐招平.下尿路感染患者尿液病原菌分布及耐药性分析[J].贵州医药,2020,44(8):1279-1281.[2]李雯雯,朱肖露,朴文花,等.478例糖尿病合并尿路感染患者的病原菌分布及耐药性分析[J].宁夏医科大学学报,2020,42(4):415-418.[3]谢鸣部,邹臻寰,陈晶,等.肾内科患者尿路感染病原菌分布及耐药性分析[J].中国病原生物学杂志,2020,15(2):221-224.[4]陈中举,田磊,杨为民,等.2016～2018年泌尿外科患者尿路感染病原菌分布及耐药性分析[J].临床泌尿外科杂志,2020,35(2):103-107,111.[5]孙庆霞.104例非发热性下尿路感染患者中段尿细菌培养及主要致病菌分析[J].中国实验诊断学,2020,24(1):79-81.[6]周义正,肖美芳,邱晓燕,等.尿路感染相关病原菌的分布及耐药性分析[J].中国微生态学杂志,2017,29(3):333-337.[7]Farmer K,James A,Naraine R,et al.Urinary Tract Infection Escherichia coli Is Related to the Environmental Escherichia coli in Their DNA Barcoding and Antibiotic Resistance Patterns in Grenada[J].Advances in Microbiology,2016,6(1):33-46.[8]严友纪,廖星富,陈忠军,等.泌尿外科患者尿路感染病原菌分布及耐药性分析[J].海南医学,2018,29(20):2869-2872.[9]徐茜.尿路感染患者病原菌谱与耐药性及尿常规诊疗价值分析[J].检验医学与临床,2018,15(13):1995-1998.[10]解泽强,陈亮,张曼.2016～2017年泌尿系感染病原菌特征分析[J].标记免疫分析与临床,2018,25(5):610-615.[11]张恩,李霞,常燕子.泌尿道感染病原菌分布及药敏性分析[J].中国微生态学杂志,2016,28(9):1066-1068,1071.[12]Tüzün T,Say?覦n Kutlu S,Kutlu M,et al.Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli[J].Turk J Med Sci,2019,49(4):1206-1211.[13]黄吉,胡旻昊.泌尿外科尿路感染患者大肠埃希菌产超广谱β-内酰胺酶的检出率与抗菌药物使用的相关性分析[J].抗感染药学,2021,18(2):170-174.[14]管舒娴,强叶涛,宋静玉,等.2098例尿路感染病原菌分布与耐药性分析[J].检验医学与临床,2019,16(16):2309-2312,2315.[15]李莉,高晶,彭怡倩,等.妇产科患者尿路感染的菌群分布及耐药性分析[J].中华医院感染学杂志,2017,27(10):2352-2355.[16]李美红,王峰,李春仙.尿路感染的主要病原菌及耐药性分析[J].中国消毒学杂志,2016,33(11):1122-1124.[17]胡跃世,李鹏,曹志华,等.前列腺增生症患者尿路感染的病原菌与耐药性分析[J].中华医院感染学杂志,2016,26(14):3273-3274,3280.[18]杨运彩,周君琳,昌建明.导尿管相关尿路感染的病原菌特点与耐药性分析[J].中国消毒学杂志,2017,34(10):986-988.[19]Olagunju AO,Nasirova S,Muganlinskaya N.Streptococcus agalactiae-Induced Soft Tissue Infection in a Nonpregnant Adult After a Gynecological Procedure[J].American Journal of Case Reports,2020,21(7):e924110.

相似文献/References:

[1]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
　LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(23):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[2]雷 欣,陈筱云.糖尿病合并尿路感染中医临证治验[J].医学信息,2021,34(07):162.[doi:10.3969/j.issn.1006-1959.2021.07.046]
[3]茹银转,胡桂贞,陈云开,等.2018年~2020年某基层医院尿路感染的细菌分布及耐药状况调查[J].医学信息,2021,34(12):148.[doi:10.3969/j.issn.1006-1959.2021.12.040]
　RU Yin-zhuan,HU Gui-zhen,CHEN Yun-kai,et al.Survey of Bacterial Distribution and Drug Resistance of Urinary Tract Infections in a Primary Hospital from 2018 to 2020[J].Journal of Medical Information,2021,34(23):148.[doi:10.3969/j.issn.1006-1959.2021.12.040]
[4]魏长斌.头孢哌酮钠舒巴坦钠对糖尿病合并尿路感染的疗效及安全性分析[J].医学信息,2021,34(14):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
　WEI Chang-bin.Analysis of the Efficacy and Safety of Cefoperazone Sodium and Sulbactam Sodium on Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2021,34(23):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
[5]肖春芳.尿路感染患者奇异变形杆菌分布及耐药性分析[J].医学信息,2021,34(24):187.[doi:10.3969/j.issn.1006-1959.2021.24.051]
　XIAO Chun-fang.Distribution and Drug Resistance of Proteus Mirabilis in Patients with Urinary Tract Infection[J].Journal of Medical Information,2021,34(23):187.[doi:10.3969/j.issn.1006-1959.2021.24.051]
[6]邹 莉,邹长娇,陈丽华.新型泌尿外科护理管理模式对外科住院患者治疗及降低院内尿路感染的影响[J].医学信息,2024,37(05):161.[doi:10.3969/j.issn.1006-1959.2024.05.030]
　ZOU Li,ZOU Chang-jiao,CHEN Li-hua.Effect of New Urological Nursing Management Model on the Treatment and the Reduction of Nosocomial Urinary Tract Infection for Surgical Inpatients[J].Journal of Medical Information,2024,37(23):161.[doi:10.3969/j.issn.1006-1959.2024.05.030]

更新日期/Last Update: 1900-01-01